Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study.
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study.
复制标题
DOI:
10.1136/bmj.d4044
复制
发表时间:
2011-07-28
期刊:
影响因子:
--
通讯作者:
Capewell S
中科院分区:
文献类型:
--
作者:
Barton P;Andronis L;Briggs A;McPherson K;Capewell S
Objective To estimate the potential cost effectiveness of a population-wide risk factor reduction programme aimed at preventing cardiovascular disease. Design Economic modelling analysis. Setting England and Wales. Population Entire population. Model Spreadsheet model to quantify the reduction in cardiovascular disease over a decade, assuming the benefits apply consistently for men and women across age and risk groups. Main outcome measures Cardiovascular events avoided, quality adjusted life years gained, and savings in healthcare costs for a given effectiveness; estimates of how much it would be worth spending to achieve a specific outcome. Results A programme across the entire population of England and Wales (about 50 million people) that reduced cardiovascular events by just 1% would result in savings to the health service worth at least £30m (€34m; $48m) a year compared with no additional intervention. Reducing mean cholesterol concentrations or blood pressure levels in the population by 5% (as already achieved by similar interventions in some other countries) would result in annual savings worth at least £80m to £100m. Legislation or other measures to reduce dietary salt intake by 3 g/day (current mean intake approximately 8.5 g/day) would prevent approximately 30 000 cardiovascular events, with savings worth at least £40m a year. Legislation to reduce intake of industrial trans fatty acid by approximately 0.5% of total energy content might gain around 570 000 life years and generate NHS savings worth at least £230m a year. Conclusions Any intervention that achieved even a modest population-wide reduction in any major cardiovascular risk factor would produce a net cost saving to the NHS, as well as improving health. Given the conservative assumptions used in this model, the true benefits would probably be greater.
登录
查看更多内容
影响因子:
39.3
作者:
Bjorck, Lena;Rosengren, Annika;Capewell, Simon
通讯作者:
Capewell, Simon
DOI:
10.1056/nejmoa0907355
发表时间:
2010-02-18
期刊:
The New England journal of medicine
影响因子:
--
作者:
Bibbins-Domingo K;Chertow GM;Coxson PG;Moran A;Lightwood JM;Pletcher MJ;Goldman L
通讯作者:
Goldman L
DOI:
10.1136/bmj.c2442
发表时间:
2010-05-13
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Collins GS;Altman DG
通讯作者:
Altman DG
影响因子:
3.7
作者:
Aspelund T;Gudnason V;Magnusdottir BT;Andersen K;Sigurdsson G;Thorsson B;Steingrimsdottir L;Critchley J;Bennett K;O'Flaherty M;Capewell S
通讯作者:
Capewell S
DOI:
10.2471/blt.08.057885
发表时间:
2010-02-01
期刊:
Bulletin of the World Health Organization: International Journal of Public Health
影响因子:
--
作者:
Capewell, Simon;Ford, Earl S;Labarthe, Darwin R
通讯作者:
Labarthe, Darwin R